|
Volumn 114, Issue 15, 2006, Pages
|
Letter by Cameron et al regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) Study" [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE;
ANTIHYPERTENSIVE AGENT;
PERINDOPRIL;
AORTA PRESSURE;
BLOOD PRESSURE REGULATION;
CALIBRATION;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG EFFICACY;
EVALUATION;
HEART RATE;
HUMAN;
HYPERTENSION;
LETTER;
NON INVASIVE MEASUREMENT;
OUTCOME ASSESSMENT;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
PULSE PRESSURE;
SPHYGMOMANOMETRY;
SYSTOLIC BLOOD PRESSURE;
WAVEFORM;
ADRENERGIC BETA-ANTAGONISTS;
AMLODIPINE;
ANTIHYPERTENSIVE AGENTS;
AORTA;
ATENOLOL;
BLOOD PRESSURE;
HEART RATE;
HUMANS;
HYPERTENSION;
PROPORTIONAL HAZARDS MODELS;
STROKE VOLUME;
TREATMENT OUTCOME;
|
EID: 33749626646
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.106.628842 Document Type: Letter |
Times cited : (1)
|
References (5)
|